Registry for Patients With Lipodystrophy
Studying Acquired generalized lipodystrophy
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- University of Ulm
- Principal Investigator
- Martin Wabitsch, Prof. Dr.University of Ulm
- Enrollment
- 5000 enrolled
- Eligibility
- All sexes
- Timeline
- 2017 – 2068
Study locations (28)
- Medical University of Vienna, Vienna, Austria
- Lille University, Lille, France
- AP-HP Nord Université de Paris, Hôpital Universitaire Robert-Debré, Paris, France
- Pierre et Marie Curie School of Medicine, Sorbonne University, Paris, France
- Kinder-und Jugendkrankenhaus AUF DER BULT, Hanover, Germany
- Department of Internal Medicine (Endocrinology and Nephrology), University of Leipzig, Leipzig, Germany
- Med. Klinik B für Gastroenterologie und Hepatologie, Universitätsklinikum Münster, Münster, Germany
- Dept for Pediatrics and Adolescent Medicine, University of Ulm: Interdisciplinary obesity clinic, Ulm, Germany
- National and Kapodistrian University of Athens, Athens, Greece
- Second Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece
- University of Szeged, Department of Internal Medicine, Szeged, Hungary
- Endocrinology Unit, Department of Clinical and Medical science, S. Orsola-Malpighi Hospital , University of Bologna, Bologna, Italy
- Policlinic University Hospital of Milan, Milan, Italy
- Universita del piemonte Orientale, Novara, Italy
- Palermo University, Palermo, Italy
- +13 more locations on ClinicalTrials.gov
Collaborators
Sorbonne University · University Hospital, Lille · University of Cambridge · Endocrinology Research Centre, Moscow · University of Leipzig · University of Amsterdam · Dokuz Eylul University · IRCCS Azienda Ospedaliero-Universitaria di Bologna · University of Rome Tor Vergata · University of Pisa · University of Santiago de Compostela · Università degli Studi del Piemonte Orientale Amedeo Avogadro · University Hospital Muenster · Szeged University · Centro Hospitalar do Porto · University Medical Centre Ljubljana · Medical University of Vienna · National and Kapodistrian University of Athens · Stoffwechselzentrum St. Gallen · National Taiwan University Hospital · Marmara University · University of Palermo · Attikon Hospital · Kinderkrankenhaus auf der Bult · Hopital Universitaire Robert-Debre · University of Milan · C.I. Parhon National Institute of Endocrinology
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03553420 on ClinicalTrials.govOther trials for Acquired generalized lipodystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07220785Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized LipodystrophyRegeneron Pharmaceuticals
- RECRUITINGPHASE3NCT06502990Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised LipodystrophyAmryt Pharma
- ACTIVE NOT RECRUITINGPHASE3NCT06548100A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)Regeneron Pharmaceuticals
- ACTIVE NOT RECRUITINGNANCT03936829Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 DiabetesChildren's Hospital of Fudan University
- ACTIVE NOT RECRUITINGPHASE3NCT02262832Compassionate Use of Metreleptin in Previously Treated People With Generalized LipodystrophyNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)